Erlotinib Terminated Phase 1 Trials for Advanced Solid Tumors Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01284335A Safety Study in Participants With Advanced Solid Tumors